BECTON, DICKINSON AND COMPANY Net Fee Amt
BECTON, DICKINSON AND COMPANY (BDX) had Net Fee Amt of $107.30 thousand as of 2026-05-04, per its S-8 filed 2026-05-07.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-07
- 2026-05-04: Net Fee Amt $107.30K.
| Period end | Net Fee Amt |
|---|---|
| 2026-05-04 | $107.30K S-8 · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |